F. Quitkin

C E Tenke, C. Tenke, J. Kayser, 2000, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants.

J. Stewart, P. McGrath, G. Bruder, 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes.

J. Stewart, G. Bruder, W. Harrison, 1989, Journal of abnormal psychology.

Does mirtazapine have a more rapid onset than SSRIs?

F. Quitkin, B. Taylor, C. Kremer, 2001, The Journal of clinical psychiatry.

Adverse Reactions to Monoamine Oxidase Inhibitors. Part II. Treatment Correlates and Clinical Management

J. Rabkin, P. McGrath, W. Harrison, 1985, Journal of clinical psychopharmacology.

Adverse Reactions to Monoamine Oxidase Inhibitors. Part I. A Comparative Study

J. Rabkin, P. McGrath, W. Harrison, 1984, Journal of clinical psychopharmacology.

Determination of mianserin and metabolites in plasma by liquid chromatography with electrochemical detection.

T. Cooper, R. Suckow, F. Quitkin, 1982, Journal of pharmaceutical sciences.

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.

J. Stewart, P. McGrath, E. Nunes, 1996, Archives of general psychiatry.

Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use.

J. Stewart, E. Nunes, F. Quitkin, 1991, The American journal of psychiatry.

Antidepressant specificity in atypical depression.

D. Klein, M. Liebowitz, J. Rabkin, 1988, Archives of general psychiatry.

Bromocriptine treatment of relapses seen during selective serotonin re-uptake inhibitor treatment of depression.

D. Klein, P. McGrath, F. Quitkin, 1995, Journal of clinical psychopharmacology.

Low B6 levels in depressed outpatients.

J. Stewart, W. Harrison, F. Quitkin, 1984, Biological Psychiatry.

Light therapy for seasonal affective disorder. A review of efficacy.

M Terman, P J McGrath, J. Stewart, 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Phenelzine treatment of melancholia.

J. Stewart, P. McGrath, W. Harrison, 1986, The Journal of clinical psychiatry.

Social networks and methadone treatment outcome: the costs and benefits of social ties.

F. Quitkin, E. Nunes, L. Goehl, 1993, The American journal of drug and alcohol abuse.

Effects of antidepressant medication on sexual function: a controlled study.

J. Rabkin, J. Stewart, P. McGrath, 1986, Journal of clinical psychopharmacology.

Lithium treatment for cocaine abusers with bipolar spectrum disorders.

P. McGrath, E. Nunes, F. Quitkin, 1990, The American journal of psychiatry.

Atypical depression. A valid clinical entity?

P J McGrath, J. Rabkin, J. Stewart, 1993, The Psychiatric clinics of North America.

Follow-up of patients who improved during placebo washout.

J. Rabkin, J. Stewart, P. McGrath, 1986, Journal of clinical psychopharmacology.

Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.

D. Klein, M. Liebowitz, J. Stewart, 1983, Archives of general psychiatry.

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

J. Amsterdam, M. Fava, J. Rosenbaum, 1994, The American journal of psychiatry.

Validity of clinical trials of antidepressants.

D. Klein, J. Rabkin, J. Davis, 2000, The American journal of psychiatry.

Hidden Psychiatric Diagnosis in the Alcoholic

J. Rabkin, F. Quitkin, 1982 .

MAOIs and hypertensive crises: the role of OTC drugs.

J. Stewart, P. McGrath, W. Harrison, 1989, The Journal of clinical psychiatry.

Placebo run-in period in studies of depressive disorders

D. Klein, E. Petkova, J. Stewart, 1998, British Journal of Psychiatry.

Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.

P. McGrath, E. Nunes, G. Woody, 1998, Archives of general psychiatry.

Depression With Atypical Features: Diagnostic Validity, Prevalence, and Treatment.

F. Quitkin, 2002, Primary care companion to the Journal of clinical psychiatry.

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

E. Susser, F. Quitkin, D. Klein, 2000, The American journal of psychiatry.

Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.

J. Stewart, P. McGrath, F. Quitkin, 1994, Journal of clinical psychopharmacology.

Unusual Side Effects of Clomipramine Associated with Yawning

J. Stewart, P. McGrath, W. Harrison, 1984, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A Subgroup of Depressives with Better Response to MAOI than to Tricyclic Antidepressants or Placebo

D. Klein, J. Rabkin, J. Stewart, 2018 .

Response to maintenance therapy in bipolar illness. Effect of index episode.

J. Fleiss, F. Quitkin, D. Shapiro, 1989, Archives of general psychiatry.

Phenelzine‐Induced Pyridoxine Deficiency

M. Liebowitz, J. Stewart, W. Harrison, 1984, Journal of clinical psychopharmacology.

Bipolar Disorder: Are There Manic-Prone and

J. Rabkin, F. Quitkin, R. Prien, 1986 .

Bipolar disorder: are there manic-prone and depressive-prone forms?

J. Rabkin, F. Quitkin, R. Prien, 1986, Journal of clinical psychopharmacology.

Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report.

J. Stewart, E. Nunes, F. Quitkin, 1991, The International journal of the addictions.

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.

J. Amsterdam, J. Rosenbaum, J. Stewart, 1998, Archives of general psychiatry.

Current concepts in the treatment of depression in alcohol-dependent patients.

P. McGrath, E. Nunes, F. Quitkin, 2000, The Psychiatric clinics of North America.

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

D. Klein, J. Rabkin, J. Stewart, 1989, Archives of general psychiatry.

Defining the boundaries of atypical depression.

M. Liebowitz, J. Rabkin, P. McGrath, 1984, The Journal of clinical psychiatry.

Sleep of atypical depressives.

R. Goetz, J. Rabkin, J. Stewart, 1985, Journal of affective disorders.

Atypical depression: current status and relevance to melancholia

D. Klein, J. Stewart, P. McGrath, 2007 .

Are there differences between women's and men's antidepressant responses?

D. Klein, E. Petkova, J. Stewart, 2002, The American journal of psychiatry.

The identification and validation of distinct depressive syndromes in a population-based sample of female twins.

D. Klein, J. Stewart, P. McGrath, 1997, Archives of general psychiatry.

Imipramine treatment of cocaine abuse: possible boundaries of efficacy.

D. Klein, J. Stewart, P. McGrath, 1995, Drug and alcohol dependence.

A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.

D. Klein, J. Rabkin, J. Stewart, 1993, The American journal of psychiatry.

Treatment of Depression in Drug-Dependent Patients : Effects on Mood and Drug Use

E. Nunes, F. Quitkin, 1997 .

Treatment of Depression in Alcohol-Dependent Patients

P. McGrath, E. Nunes, F. Quitkin, 1997 .

Panic disorder and depression in female alcoholics.

F. Quitkin, E. Nunes, C. Berman, 1988, The Journal of clinical psychiatry.

A possible L-deprenyl induced hypertensive reaction.

J. Stewart, P. McGrath, F. Quitkin, 1989, Journal of clinical psychopharmacology.

Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.

J. Rabkin, J. Stewart, P. McGrath, 1989, Psychopharmacology bulletin.

Antidepressant treatment in methadone maintenance patients.

E. Nunes, F. Quitkin, R. Brady, 1995, Journal of addictive diseases.

A placebo-controlled trial of L-deprenyl in atypical depression.

J. Stewart, P. McGrath, W. Harrison, 1989, Psychopharmacology bulletin.

Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.

J. Stewart, P. McGrath, W. Harrison, 1987, Psychopharmacology bulletin.

Duration of antidepressant trials: clinical and research implications.

J. Stewart, P. McGrath, E. Nunes, 1994, Journal of clinical psychopharmacology.

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

D. Kupfer, M. Fava, A. Rush, 2003, The Psychiatric clinics of North America.

Different types of placebo response in patients receiving antidepressants.

J. Fleiss, D. Klein, J. Rabkin, 1991, The American journal of psychiatry.

Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.

J. Amsterdam, M. Fava, F. Quitkin, 1998, The American journal of psychiatry.

Fluoxetine efficacy in menopausal women with and without estrogen replacement.

J. Amsterdam, F. Quitkin, J. Rosenbaum, 1999, Journal of affective disorders.

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

D. Kupfer, B. Lebowitz, M. Fava, 2004, Controlled clinical trials.

Is loss of antidepressant effect during continuation therapy related to placebo effect?

J. Stewart, P. McGrath, W. Harrison, 1988, Psychopharmacology bulletin.

Dichotic Listening Tests of Functional Brain Asymmetry Predict Response to Fluoxetine in Depressed Women and Men

F. Quitkin, J. Stewart, P. McGrath, 2004, Neuropsychopharmacology.

Norms for depressed patients for the California verbal learning test: associations with depression severity and self-report of cognitive difficulties.

D. Delis, M. Fava, F. Quitkin, 1994, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder

F. Quitkin, J. M. German, P. McGrath, 2005, Journal of Neural Transmission.

Somatization as a predictor of medication discontinuation due to adverse events

J. Stewart, P. McGrath, F. Quitkin, 2002, International clinical psychopharmacology.

The dexamethasone suppression test with mildly to moderately depressed outpatients.

J. Rabkin, J. Stewart, P. McGrath, 1983, The American journal of psychiatry.

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.

J. Amsterdam, F. Quitkin, J. Rosenbaum, 1997, The American journal of psychiatry.

Gender differences in treatment response.

J. Stewart, P. McGrath, F. Quitkin, 2001, The American journal of psychiatry.

Further Evidence That a Placebo Response to Antidepressants Can Be Identified

D. Klein, J. Rabkin, J. Stewart, 1993 .

Treatment of premenstrual dysphoric symptoms in depressed women.

J. Endicott, P. McGrath, W. Harrison, 1991, Journal of the American Medical Women's Association.

What conditions are necessary to assess antidepressant efficacy?

F. Quitkin, D. Klein, F. Quitkin, 2000, Archives of general psychiatry.

Treatment of Atypical Depression: Phenelzine, Imipramine, and Placebo

D. Klein, M. Liebowitz, J. Rabkin, 1986 .

Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.

J. Amsterdam, F. Quitkin, J. Rosenbaum, 1998, Journal of clinical psychopharmacology.

The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.

D. Klein, M. Liebowitz, J. Rabkin, 1984 .

Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.

P J McGrath, J. Amsterdam, F. Quitkin, 2000, The Journal of clinical psychiatry.

How symptomatic do depressed patients remain after benefiting from medication treatment?

J. Stewart, F. Quitkin, K. Ocepek-Welikson, 1993, Comprehensive psychiatry.

A controlled study of the effects of antidepressants on sexual function.

M. Liebowitz, J. Rabkin, P. McGrath, 1985, Psychopharmacology bulletin.

Monoamine Oxidase Inhibitors in Bipolar Endogenous Depressives

M. Liebowitz, P. McGrath, F. Quitkin, 1981, Journal of clinical psychopharmacology.